-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $113

Benzinga·11/05/2026 15:14:19
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $113.